Hopp til innhold
NHI.no
Annonse

Parvovirusinfeksjon: Smitte

Innhold i artikkelen

Virus overføres ved dråpesmitte (luftsmitte), blodsmitte eller direkte fra gravid til foster. Smitterisikoen er cirka 50 prosent for dem som lever sammen med infiserte personer, og cirka 20-30 prosent blant dem som deler av dagen er utsatt for infiserte barn (lærere, dagmammaer). Inkubasjonstiden varierer fra 4-14 dager, men den kan være så lang som 21 dager. Sykdommen smitter ikke lenger når utslettet kommer, fordi det da har dannet seg antistoffer. 

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Parvovirusinfeksjoner . Referanselisten for dette dokumentet vises nedenfor

  1. Servey JT, Reamy BV, Hodge J. Clinical presentations of parvovirus B19 infection. Am Fam Physician 2007; 75: 373-6. PubMed
  2. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002; 15: 485-505. PubMed
  3. Jordan JA. Clinical manifestations and diagnosis of parvovirus B19 infection. UpToDate, last updated Dec 15, 2014. UpToDate
  4. Parvovirus B19 (erythema infectiosum, fifth disease). In: Red Book 2006: Report of the Committee on Infectious Diseases. 27th ed. Washington, D.C.: American Academy of Pediatrics, 2006: 484-7.
  5. Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvoviral infection in humans. J Infect Dis 1985; 152: 257. pmid:2993431 PubMed
  6. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350: 586-97. New England Journal of Medicine
  7. Nesher G, Moore TL. Human parvovirus infection. Infect Med 1997; 14: 638-42. PubMed
  8. Naides SJ, Scharosch LL, Foto F, Howard EJ. Rheumatologic manifestations of human parvovirus B19 infection in adults. Arthritis Rheum 1990; 33: 1297-309. PubMed
  9. Smith-Whitley K, Zhao H, Hodinka RL, Kwiatkowski J, Cecil R, Cecil T, et al. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood 2004; 103: 422-7. Blood
  10. Posfay-Barbe KM, Michaels MG. Parvovirus B19 in organ transplant recipients. Curr Opin Organ Transpl 2003; 8: 283-7. PubMed
  11. Alfadley A, Aljubran A, Hainau B, Alhokail A. Papular-purpuric "gloves and socks" syndrome in a mother and daughter. J Am Acad Dermatol 2003; 48: 941-4. PubMed
  12. Metry D, Katta R. New and emerging pediatric infections. Dermatol Clin 2003; 21: 269-76. PubMed
  13. Katta R. Parvovirus B19: a review. Dermatol Clin 2002; 20: 333-42. PubMed
  14. Edmonson MB, Riedesel EL, Williams GP, Demuri GP. Generalized petechial rashes in children during a parvovirus B19 outbreak. Pediatrics 2010; 125: 787-92. Pediatrics
  15. Alger LS. Toxoplasmosis and parvovirus B19. Infect Dis Clin North Am 1997; 11: 55-75. PubMed
  16. Folkehelseinstituttet. Erythema infectiosum (femte barnesykdom) - veileder for helsepersonell. Sist oppdatert 07.2014. www.fhi.no
  17. American College of Obstetrics and Gynecologists. ACOG practice bulletin. Perinatal viral and parasitic infections. Number 20, September 2000. Int J Gynaecol Obstet 2002; 76: 95-107. PubMed
  18. Institute for Clinical Systems Improvement. Prenatal care, routine. Accessed June 9, 2006, at: http://www.icsi.org/knowledge/detail.asp?catID=29&itemID=191.
  19. Doyle S, Kerr S, O'Keeffe G, O'Carroll D, Daly P, Kilty C. Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis. J Virol Methods 2000; 90: 143-52. PubMed
  20. Ballou WR, Reed JL, Noble W, Young NS, Koenig S. Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1. J Infect Dis 2003; 187: 675-8. PubMed
Annonse
Annonse